Logo image of ADES

ADVANCED EMISSIONS SOLUTIONS (ADES) Stock Fundamental Analysis

NASDAQ:ADES - Nasdaq - US00770C1018 - Common Stock - Currency: USD

3.36  +0.1 (+3.07%)

Fundamental Rating

3

Overall ADES gets a fundamental rating of 3 out of 10. We evaluated ADES against 84 industry peers in the Chemicals industry. The financial health of ADES is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ADES is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ADES had negative earnings in the past year.
In the past year ADES has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ADES reported negative net income in multiple years.
In multiple years ADES reported negative operating cash flow during the last 5 years.
ADES Yearly Net Income VS EBIT VS OCF VS FCFADES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

ADES has a worse Return On Assets (-8.19%) than 84.88% of its industry peers.
The Return On Equity of ADES (-10.83%) is worse than 79.07% of its industry peers.
Industry RankSector Rank
ROA -8.19%
ROE -10.83%
ROIC N/A
ROA(3y)4.61%
ROA(5y)11.27%
ROE(3y)3.61%
ROE(5y)19.12%
ROIC(3y)N/A
ROIC(5y)N/A
ADES Yearly ROA, ROE, ROICADES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 100 -100

1.3 Margins

ADES has a Gross Margin of 25.19%. This is comparable to the rest of the industry: ADES outperforms 50.00% of its industry peers.
ADES's Gross Margin has declined in the last couple of years.
ADES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.41%
GM growth 5Y-5.98%
ADES Yearly Profit, Operating, Gross MarginsADES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 100 150

More info and screens

5

2. Health

2.1 Basic Checks

ADES does not have a ROIC to compare to the WACC, probably because it is not profitable.
ADES has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ADES is higher compared to a year ago.
ADES Yearly Shares OutstandingADES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
ADES Yearly Total Debt VS Total AssetsADES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

ADES has an Altman-Z score of 2.05. This is not the best score and indicates that ADES is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ADES (2.05) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.11 indicates that ADES is not too dependend on debt financing.
ADES has a better Debt to Equity ratio (0.11) than 80.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 2.05
ROIC/WACCN/A
WACC8.68%
ADES Yearly LT Debt VS Equity VS FCFADES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

A Current Ratio of 4.16 indicates that ADES has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.16, ADES belongs to the top of the industry, outperforming 83.72% of the companies in the same industry.
ADES has a Quick Ratio of 3.32. This indicates that ADES is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ADES (3.32) is better than 86.05% of its industry peers.
Industry RankSector Rank
Current Ratio 4.16
Quick Ratio 3.32
ADES Yearly Current Assets VS Current LiabilitesADES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ADES have decreased strongly by -7600.00% in the last year.
ADES shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.29%.
Measured over the past years, ADES shows a quite strong growth in Revenue. The Revenue has been growing by 17.80% on average per year.
EPS 1Y (TTM)-7600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.15%
Revenue 1Y (TTM)-10.29%
Revenue growth 3Y13.69%
Revenue growth 5Y17.8%
Sales Q2Q%4.89%

3.2 Future

The Earnings Per Share is expected to grow by 31.11% on average over the next years. This is a very strong growth
ADES is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.65% yearly.
EPS Next Y-31.14%
EPS Next 2Y28.3%
EPS Next 3Y32.63%
EPS Next 5Y31.11%
Revenue Next Year-2.95%
Revenue Next 2Y1.58%
Revenue Next 3Y11.05%
Revenue Next 5Y13.65%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ADES Yearly Revenue VS EstimatesADES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ADES Yearly EPS VS EstimatesADES Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 0 1 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ADES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ADES is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADES Price Earnings VS Forward Price EarningsADES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADES Per share dataADES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as ADES's earnings are expected to grow with 32.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.3%
EPS Next 3Y32.63%

More info and screens

0

5. Dividend

5.1 Amount

ADES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADVANCED EMISSIONS SOLUTIONS

NASDAQ:ADES (1/31/2024, 8:00:00 PM)

3.36

+0.1 (+3.07%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)03-06 2024-03-06/amc
Inst Owners47.41%
Inst Owner Change3.79%
Ins Owners17.93%
Ins Owner Change0%
Market Cap111.48M
Analysts82.86
Price Target6.12 (82.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-67.64%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.47%
Min EPS beat(2)-28.68%
Max EPS beat(2)37.61%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.29%
Min Revenue beat(2)14.69%
Max Revenue beat(2)15.89%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)0%
EPS NY rev (3m)12.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.18
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS2.85
BVpS5.25
TBVpS5.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.19%
ROE -10.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.19%
FCFM N/A
ROA(3y)4.61%
ROA(5y)11.27%
ROE(3y)3.61%
ROE(5y)19.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.41%
GM growth 5Y-5.98%
F-Score1
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 244.57%
Cap/Sales 23.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.16
Quick Ratio 3.32
Altman-Z 2.05
F-Score1
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)110.43%
Cap/Depr(5y)113.45%
Cap/Sales(3y)9.29%
Cap/Sales(5y)9.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.15%
EPS Next Y-31.14%
EPS Next 2Y28.3%
EPS Next 3Y32.63%
EPS Next 5Y31.11%
Revenue 1Y (TTM)-10.29%
Revenue growth 3Y13.69%
Revenue growth 5Y17.8%
Sales Q2Q%4.89%
Revenue Next Year-2.95%
Revenue Next 2Y1.58%
Revenue Next 3Y11.05%
Revenue Next 5Y13.65%
EBIT growth 1Y-160.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.64%
EBIT Next 3Y52.56%
EBIT Next 5Y44.46%
FCF growth 1Y-240.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-162.89%
OCF growth 3YN/A
OCF growth 5YN/A